Developing & Upscaling High-Throughput Manufacture of SARS-CoV-2 Testing Kits

The COVID-19 pandemic created an immediate need for high volumes of affordable and effective SARS-CoV-2 testing kits. To produce enough rapid antigen test kits to help meet the global needs for testing, a high-throughput, automated production workflow was required.

US based InBios, a leading biotechnology company, utilized eight Ginolis Lateral Flow Device Assembly (LFDA) semi-automated and automated systems in a series. By doing this InBios upscaled production of rapid antigen test kits 20-fold, which enabled them to produce kits at a scale needed to contribute significantly to emergency demands for testing.

More Customer Spotlights

Contact us!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.